NIOSH proposes additions to hazardous list drug list

By: David LaHoda May 22nd, 2009

NIOSH has posted the proposed additions to its hazardous drug list in healthcare settings, which was last updated September 2004.

The list, which is undergoing public review until June 30 identifies 24 new pharmaceuticals that fit the NIOSH definition of hazardous drugs. One drug, Bacillus Calmette-Guerin, will be removed from the 2004 list.

By OSHA regulation, employers must obtain a material data sheet (MSDS) for hazardous drugs in non-solid form with exposure potential to employees. For help in determining what chemicals and drugs in your facility need an MSDS, download the “Determining When an MSDS Is Necessary” decision tree from the Tools page.

View the proposed changes on the NIOSH hazardous drug public review and comment web page.

« Ventilation in the autopsy suite | Home | Aerosol transmissible disease standard approved for California »

David LaHoda



David LaHoda, the managing editor of Medical Environment Update and OSHA Watch, has produced healthcare training videos and consulted for medical practices and ambulatory healthcare facilities.

David has written 196 posts.

• Categories

  • Ask the Expert—Bloodborne Pathogens
  • Ask the expert—General OSHA
  • Ask the Expert—Hazard Communication
  • Bloodborne Pathogens
  • Emergency Action Plans
  • Featured
  • First Aid
  • General Safety and Health
  • Hazardous Waste
  • Infection Control
  • Lab Safety
  • Needlesticks & Sharps Injuries
  • Notes from the field
  • OSHA – Citations & Fines
  • OSHA – General
  • Pandemic Influenza
  • Popular
  • Uncategorized
  • Waste Management
  • Weekly Poll Questions

• Archives

  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008

• Feeds

  • Subscribe to RSS Feed
  • Subscribe to Comments